Abstract
In an era of an aging population with increased age-related cancer incidence, clinicians should expect that they will have to care for an ever growing number of elderly cancer patients. Colorectal cancer is the third most common cancer and the second most common cause of mortality in people aged over 65.
Whether at the screening, diagnosis, or treatment stage, there remains suboptimal treatment of cancer in the elderly. In most cases, the life expectancy of an elderly patient is often underestimated by the family and the physician. Underestimating the potential impact of cancer and life expectancy can expose an elderly patient to a high risk of loss of autonomy and of deterioration in the quality of life.
Colorectal cancer treatments are usually standardized but elderly patients may harbor multiple comorbidities, poor health status, geriatrics syndromes, and loss of functional reserve that will interfere with the treatment of the cancer itself. Optimizing these, complex patient relies on an accurate prediction of outcomes. Till today, no standardized assessment can be recommended. Studies are ongoing to find the best screening tools, best geriatric assessment, and best interventions especially in the setting of surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aapro MS, Kohne CH, Cohen HJ et al (2005) Never too old? Age should not be a barrier to enrolment in cancer clinical trials. Oncologist 10:198–204
Aouba A, Péquignot F, Le Toullec A, et al (2007) Les causes médicales de décès en France en 2004 et leur évolution 1980–2004. Bulletin Epidémiologique Hebdomadaire 35–36:308–14. http://www.insee.fr
Aparicio T, Mitry E, Sa Cunha A et al (2005) Management of colorectal cancer of elderly patients. Gastroenterol Clin Biol 29:1014–1023
Aparicio T, Navazesh A, Boutron I et al (2009) Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol 71:249–257
Aparicio T, Bouché O, Carola E et al (2010) Recommandations du GEPOG (Groupe d’ Echanges et de Pratique en Onco-Geriatrie) pour le traitement des cancers colorectaux métastatiques des patients âgés. Journal d’Onco-Gériatrie 3(4):157–163
Balducci L, Beghe C (2000) The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 35:147–154
Benson AB III, Pregler JP, Bean JA et al (1991) Oncologists’ reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol 9:2067–2075
Bernabei R, Venturiero V, Tarsitani P et al (2000) The comprehensive geriatric assessment: when, where, how. Crit Rev Oncol Hematol 33:45–56
Brouquet A, Cudennec T, Benoist S et al (2010) Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. Ann Surg 251:759–765
Carreca I, Balducci L, Extermann M (2005) Cancer in the older person. Cancer Treat Rev 31:380–402
Chen CC, Kenefick AL, Tang ST et al (2004) Utilization of comprehensive geriatric assessment in cancer patients. Crit Rev Oncol Hematol 49:53–67
Dasgupta M, Dumbrell AC (2006) Preoperative risk assessment for delirium after noncardiac surgery: a systematic review. J Am Geriatr Soc 54:1578–1589
Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92:550–556
Extermann M, Aapro M, Bernabei R, Task Force on CGA of the International Society of Geriatric Oncology et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55:241–252
Extermann M, Boler I, Reich RR et al (2011) Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. doi:10.1002/cncr.26646
Fentiman IS, Tirelli U, Monfardini S et al (1990) Cancer in the elderly: why so badly treated? Lancet 335:1020–1022
Ferrucci L, Guralnik JM, Cavazzini C et al (2003) The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol 46:127–137
Goodwin JS, Hunt WC, Samet JM (1993) Determinants of cancer therapy in elderly patients. Cancer 72:594–601
Goodwin JS, Samet JM, Hunt WC (1996) Determinants of survival in older cancer patients. J Natl Cancer Inst 88:1031–38. http://www.iinsee.fr
Hurria A, Togawa K, Mohile SG et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29:3457–3465
Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061–2067
Inouye S (2006) Delirium in older persons. N Engl J Med 354:1157–1165
Inouye S, Bogardus S, Charpentier P et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669–676
Janssen-Heijnen ML, Maas HA, Houterman S et al (2007) Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 43(15):2179–2193
Kunitake H, Zingmond D, Ryoo J et al (2010) Caring for octogenarian and nonagenarian patients with colorectal cancer: what should our standards and expectations be? Dis Colon Rectum 53:735–743
Lee SJ, Lindquist K, Segal MR et al (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295:801–808
Luciani A, Ascione G, Bertuzzi C et al (2010) Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 28:2046–2050
Maas HA, Janssen-Heijnen ML, Olde Rikkert MG et al (2007) Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 43:2161–2169
Makary MA, Segev DL, Pronovost PJ et al (2010) Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 210:901–908
Misra D, Seo PH, Cohen HJ (2004) Aging and cancer. Clin Adv Hematol Oncol 2:457–465
Papamichael D, Audisio R, Horiot J-C et al (2009) Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol 16:20–25
Puts MT, Monette J, Girre V et al (2011) Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol 78:138–149
Quipourt V, Jooste V, Cottet V et al (2011) Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study. J Am Geriatr Soc 59:694–698
Raji M, Kuo Y-F, Freeman J et al (2008) Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer implications for cancer care. Arch Intern Med 168:2033–2040
Repetto L, Venturino A, Fratino L et al (2003) Geriatric oncology: a clinical approach to the older patient with cancer. Eur J Cancer 39:870–880
Retornaz F, Monette J, Batist G et al (2008) Usefulness of frailty markers in the assessment of health and functional status of older cancer patients referred for chemotherapy: a pilot study. J Gerontol A Biol Sci Med Sci 63:518–522
Retornaz F, Potard I, Molines C et al (2010) Quand l’équipe gériatrique restaure la confiance de l’équipe médico-chirurgicale. Journal d’Onco-Gériatrie 1:33–36
Sieber F (2009) Post operative delirium in the elderly surgical patient. Anesthesiol Clin 27:451–464
Stuck AE, Siu AL, Wieland GD et al (1993) Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342:1032–1036
Tan E, Tilney H, Thompson M et al (2007) The United Kingdom national bowel cancer project – epidemiology and surgical risk in the elderly. Eur J Cancer 43:2285–2294
Tan KY, Kawamura YJ, Tokomitsu A et al (2011) Assessment for frailty is useful for predicting morbidity in elderly patients undergoing colorectal cancer resection whose comorbidities are already optimized. Am J Surg [Epub ahead of print]
Turner N, Haward R, Mulley G et al (1999) Cancer in old age: is it inadequately investigated and treated? BMJ 319:309–312
Townsley CA, Naidoo K, Pond GR et al (2003) Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns. J Clin Oncol 21:4627–4635
Tyldesley S, Zhang-Salomons J, Groome PA et al (2000) Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 47:469–480
Vercelli M, Capocaccia R, Quaglia A et al (2000) Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol 35:161–179
Walter LC, Brand RJ, Counsell SR et al (2001) Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 285(23):2987–2994
Yancik R, Ries LA (2000) Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14:17–23
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Retornaz, F., Cécile, M., Bergman, H. (2013). Rational Approach to Cancer in the Elderly. In: Tan, KY. (eds) Colorectal Cancer in the Elderly. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29883-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-29883-7_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29882-0
Online ISBN: 978-3-642-29883-7
eBook Packages: MedicineMedicine (R0)